Qizhong Yi

137 Liyushan South Road
Ueruemqi, 830054, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Association between the combination of GABAergic agents and SSRIs at the first clinical visit and depressive symptom trajectories: A study using group-based trajectory modeling and Apriori algorithm.

Association between the combination of GABAergic agents and SSRIs at the first clinical visit and depressive symptom trajectories: A study using group-based trajectory modeling and Apriori algorithm.

Journal: PLOS mental health

Published: December 14, 2025

Profiles of parental bonding and childhood trauma in a clinical sample: Implications for coping strategies in adulthood among Chinese young adults.

Profiles of parental bonding and childhood trauma in a clinical sample: Implications for coping strategies in adulthood among Chinese young adults.

Journal: Journal of affective disorders

Published: May 15, 2025

The distinct effects of metabolic syndrome on negative symptoms and on antipsychotic therapy of schizophrenia involve insular volume, functional connectivity, and genetic polymorphisms.

The distinct effects of metabolic syndrome on negative symptoms and on antipsychotic therapy of schizophrenia involve insular volume, functional connectivity, and genetic polymorphisms.

Journal: Translational psychiatry

Published: March 06, 2025

Schizophrenia and magnetic resonance imaging research: A scientometric analysis during 2014 to 2023.

Schizophrenia and magnetic resonance imaging research: A scientometric analysis during 2014 to 2023.

Journal: Medicine

Published: October 29, 2024

Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia?

Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia?

Journal: Schizophrenia (Heidelberg, Germany)

Published: October 06, 2024

The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation.

The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation.

Journal: Schizophrenia (Heidelberg, Germany)

Published: October 01, 2024

Does Academic Burnout Alleviate or Exacerbate Internet Dependence in University Students with Depression and Anxiety?

Does Academic Burnout Alleviate or Exacerbate Internet Dependence in University Students with Depression and Anxiety?

Journal: Neuropsychiatric disease and treatment

Published: June 25, 2024

Neurotransmitters crosstalk and regulation in the reward circuit of subjects with behavioral addiction.

Neurotransmitters crosstalk and regulation in the reward circuit of subjects with behavioral addiction.

Journal: Frontiers in psychiatry

Published: May 28, 2024

An Effect of Chronic Negative Stress on Hippocampal Structures and Functional Connectivity in Patients with Depressive Disorder.

An Effect of Chronic Negative Stress on Hippocampal Structures and Functional Connectivity in Patients with Depressive Disorder.

Journal: Neuropsychiatric disease and treatment

Published: February 23, 2024

Effects of Combined Therapy of Olanzapine and Samidorphan on Safety and Metabolic Parameters in Schizophrenia Patients: A Meta-Analysis.

Effects of Combined Therapy of Olanzapine and Samidorphan on Safety and Metabolic Parameters in Schizophrenia Patients: A Meta-Analysis.

Journal: Neuropsychiatric disease and treatment

Published: June 20, 2023

Profile and mental health characterization of childhood overprotection/overcontrol experiences among Chinese university students: a nationwide survey.

Profile and mental health characterization of childhood overprotection/overcontrol experiences among Chinese university students: a nationwide survey.

Journal: Frontiers in psychiatry

Published: June 11, 2023

A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder.

A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial to verify the efficacy and safety of ansofaxine (LY03005) for major depressive disorder.

Journal: Translational psychiatry

Published: October 18, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026